NM_147686.4:c.691C>T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS1_Supporting

The NM_147686.4(TRAF3IP2):​c.691C>T​(p.Leu231Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00031 in 1,549,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L231V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

TRAF3IP2
NM_147686.4 missense

Scores

1
7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.65

Publications

6 publications found
Variant links:
Genes affected
TRAF3IP2 (HGNC:1343): (TRAF3 interacting protein 2) This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene. [provided by RefSeq, Aug 2009]
TRAF3IP2-AS1 (HGNC:40005): (TRAF3IP2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.4100241).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00025 (38/152188) while in subpopulation NFE AF = 0.000558 (38/68040). AF 95% confidence interval is 0.000418. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAF3IP2NM_147686.4 linkc.691C>T p.Leu231Phe missense_variant Exon 2 of 9 ENST00000368761.11 NP_679211.2 O43734-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAF3IP2ENST00000368761.11 linkc.691C>T p.Leu231Phe missense_variant Exon 2 of 9 1 NM_147686.4 ENSP00000357750.5 O43734-2

Frequencies

GnomAD3 genomes
AF:
0.000250
AC:
38
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000558
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000293
AC:
58
AN:
197744
AF XY:
0.000256
show subpopulations
Gnomad AFR exome
AF:
0.000128
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000585
Gnomad OTH exome
AF:
0.000219
GnomAD4 exome
AF:
0.000316
AC:
442
AN:
1397172
Hom.:
0
Cov.:
31
AF XY:
0.000303
AC XY:
209
AN XY:
689158
show subpopulations
African (AFR)
AF:
0.000128
AC:
4
AN:
31132
American (AMR)
AF:
0.00
AC:
0
AN:
33402
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21360
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75720
European-Finnish (FIN)
AF:
0.0000785
AC:
4
AN:
50948
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5422
European-Non Finnish (NFE)
AF:
0.000391
AC:
423
AN:
1082546
Other (OTH)
AF:
0.000192
AC:
11
AN:
57436
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000250
AC:
38
AN:
152188
Hom.:
0
Cov.:
32
AF XY:
0.000229
AC XY:
17
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41444
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000558
AC:
38
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000384
Hom.:
0
Bravo
AF:
0.000253
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000363
AC:
44

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Candidiasis, familial, 8 Uncertain:1
Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 231 of the TRAF3IP2 protein (p.Leu231Phe). This variant is present in population databases (rs149860754, gnomAD 0.06%). This missense change has been observed in individual(s) with psoriatic arthritis (PMID: 22513239). ClinVar contains an entry for this variant (Variation ID: 573542). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TRAF3IP2 protein function. Experimental studies have shown that this missense change does not substantially affect TRAF3IP2 function (PMID: 22513239). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.14
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
.;.;T;T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Benign
0.67
D
LIST_S2
Uncertain
0.91
D;D;.;D
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.41
T;T;T;T
MetaSVM
Benign
-0.73
T
MutationAssessor
Uncertain
2.6
.;.;M;M
PhyloP100
3.7
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.9
N;N;N;.
REVEL
Benign
0.19
Sift
Pathogenic
0.0
D;D;D;.
Sift4G
Uncertain
0.015
D;D;D;D
Polyphen
1.0
D;.;D;D
Vest4
0.68
MVP
0.67
MPC
0.79
ClinPred
0.15
T
GERP RS
5.8
Varity_R
0.20
gMVP
0.21
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149860754; hg19: chr6-111912599; API